by rdbiomed | Feb 28, 2018 | pepsin, reflux
Pepsin can contribute to the pathology of a number of conditions, such as gastro-oesophageal reflux disease (GORD) and laryngopharyngeal reflux (LPR). Peptest is a highly accurate, non-invasive diagnostic test for detecting pepsin in saliva, sputum, and other clinical...
by rdbiomed | Dec 21, 2017 | Company News, reflux
Peptest has been used to evaluate the success of laparoscopic fundoplication surgery for the treatment of reflux disease in a new research study. Laparoscopic fundoplication surgery is when the top part of the stomach is wrapped around the lower part of the oesophagus...
by rdbiomed | Dec 6, 2017 | Company News, reflux
Researchers in Italy have used Peptest to investigate whether the stomach enzyme pepsin causes worsening of symptoms for patients with chronic cough and chronic respiratory disease. As part of the study at Sacro Cuore-Don Calabria Hospital in Verona, 42 patients were...
by rdbiomed | Nov 27, 2017 | pepsin, reflux
As age increases so does the tendency to suffer from laryngopharyngeal reflux (LPR) – according to a new research study. Researchers in Italy have found a significant correlation between increase in age and an increase in pepsin within the oesophagus. Pepsin is a...
by rdbiomed | Feb 22, 2017 | GERD, LPR, reflux, reflux treatments
Proton pump inhibitors (PPIs) are widely used to treat patients with gastrointestinal disorders, such as gastro-oesophageal reflux disease (GORD/GERD) and peptic ulcer. But with PPI lawsuits involving allegations of serious kidney injuries continuing to mount in the...
by rdbiomed | Feb 8, 2017 | reflux
Sleep apnea (or apnoea) is a common condition where the walls of the throat relax and narrow during sleep, interrupting normal breathing and occasionally leading to choking, snorting or gasping. According to UK charity The Sleep Apnoea Trust Association, almost 1.5...
Recent Comments